— Advanced Oncology Pipeline with FSI-189, an Anti-SIRPα Antibody; Investigational New Drug (IND) Application-Enabling Studies Expected to Begin in 2019 […]
Sustained anti-cholestatic and anti-inflammatory effects observed with no worsening of pruritus through 52 weeks Results highlight the potential for seladelpar […]